tirzepatide discontinuation Causes and consequences of of GLP1RAs or WHAT HAPPENS WHEN YOU DISCONTINUE
Description
64% below iron RDA, 72% below calcium RDA, only 1.4% met vitamin D recommendations
Let's explore this
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been pivotal for obesity treatment, achieving 1525 % weight loss over 1224 months, but questions remain about the potential influence of concomitant losses in muscle mass
are overweight or have obesity
| 12 comments on LinkedIn
